Livogrit mitigates ANIT-induced cholestasis-like symptoms in an in vivo model by curbing hepatic inflammation and regulating BAX, TGF-β, MMP-9 and α-SMA gene expression

Livogrit mitigates ANIT-induced cholestasis-like symptoms in an in vivo model by curbing hepatic inflammation and regulating BAX, TGF-β, MMP-9 and α-SMA gene expression

Bile duct constriction disrupts bile acid flow causing cholestasis, hepatic necrosis, fibrosis, and cirrhosis. The study investigated hepatoprotective effectiveness of Ayurvedic prescription herbal medicine “Livogrit” commercially available in India, against α-naphtylisothiocyanate (ANIT)-induced ch...

Full description

Saved in:
Bibliographic Details
Main Authors: Acharya Balkrishna, Ritu Paliwal, Surjeet Singh, Rani Singh, Vivek Gohel, Rishabh Dev, Kunal Bhattacharya, Sandeep Sinha, Anurag Varshney
Format: Article
Language:English
Published: Elsevier 2025-02-01
Series:Heliyon
Subjects:
Livogrit
Alpha-naphtylisothiocyanate
Cholestasis
Fibrosis
Inflammation
Ayurveda
Online Access:http://www.sciencedirect.com/science/article/pii/S240584402500235X
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items